INTRODUCTION
Autism is a neurodevelopmental disorder with a multifactorial etiology and varied presentation. In this most severe form of autistic spectrum disorder, early diagnosis is crucial to the implementation of early treatment, which can lead to immense improvement in the behavioral as well the cognitive functions of a child. We present a case of a 6-year-old child, clinically diagnosed with autism, who underwent dedicated 18F-fluorodeoxyglucose (18F-FDG) brain positron emission tomography (PET) as an ancillary and baseline investigation. In today's era, when no imaging modality exists which can diagnose autism with complete certainty, PET/computed tomography (CT) can be a valuable tool to confirm the clinical suspicion as well as rule out any other cause.
CASE REPORT
We present the case of a 6-year-old boy, born of a full term normal delivery, who had normal motor milestones as recalled of the brain parenchyma showing normal, physiological tracer distribution [ Figures 2 and 3 ]. Diffuse temporal hypometabolism did not show any corresponding structural abnormality on the corresponding CT (acquired on dedicated PET/CT scanner). No focal hyper or hypometabolic lesions were noted elsewhere in the brain parenchyma. The patient is on treatment, and follow-up imaging is awaited.
DISCUSSION
Autism spectrum disorder (ASD) is a group of complex disorders of brain development. Usually noticed by parents at the age of 3 years, autism is characterized by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interests. [1] In India, most children with ASD are diagnosed between 3 and 6 years of age. [2] The delay in diagnosis is most often due to limited knowledge among the clinicians, lack of awareness, inadequate screening, and the social stigma associated with the diagnosis. [3, 4] Early diagnosis is crucial, as it is likely that this would facilitate the recognition of underlying genetic and neurobiological mechanisms, and provide an incentive to focus on specific behavioral or biological treatment. Moreover, it has been documented that early initiation of treatment in children with ASD leads to significant improvement in language, cognition, and behavior functioning. Primary goal of the diagnosis and treatment is to improve the quality of life of the patient by maximizing functional independence, with the help of various treatment options available. The current gold standard for ASD diagnosis is considered to be clinical judgment, [5, 6] along with various screening tests and questionnaires such as CARS and M-CHAT. [7, 8] MRI has been used by several investigators to determine the presence of structural changes if any, associated with this syndrome. However, no consistent abnormalities were found on MRI. [9, 10] Dysfunction of temporal lobes has been often implicated in the etiopathogenesis of autism. This is because normal functioning of amygdala and hippocampus is essential for regulation of affect, memory, and learning. However, no structural changes have been demonstrated in these areas till today. Since the anatomic scans are normal, functional imaging may provide the best means for early diagnosis of this disorder. Though single-photon emission computed tomography (SPECT) perfusion studies are normal in many of the autism patients, it may show decreased temporal lobe perfusion. Up to 30% of autistic children eventually develop temporal lobe epilepsy. [11] PET imaging, performed with 18F-FDG, which is a radiolabeled glucose analog -the primary substrate for brain metabolism; provides improved resolution over SPECT. The neurotransmitter systems studied in ASD using PET or SPECT imaging include serotonin, dopamine, and gamma-aminobutyric acid. However, their limited availability makes their routine use challenging at present. Chivate et al. assessed 23 autistic patients and concluded that PET/CT can be a potential tool for the diagnosis of autism. [12] They demonstrated that majority of autistic patients showed low uptake in hippocampus and amygdala, followed by mesial temporal lobe and cerebellum, with high uptake in frontal lobes. The findings in our case report corroborated with what they have described. Currently, PET/SPECT imaging is not indicated in the evaluation and diagnosis of individuals who may have ASDs. However, characteristic imaging patterns on PET shall increase the diagnostic confidence of the neurophysicians in patients with strong clinical suspicion of ASD. Hence, based on the lines of this case, a larger pediatric patient population with clinical diagnosis of autism needs to be evaluated and followed up, to establish the role of PET imaging in the diagnostic algorithm of autism.
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